Clinical Observation on the Treatment of Early Pre-Eclampsia Abortion with the Combination of Enhanced “Shou Tai Wan” Soup and Progesterone

Abstract

Objective: To investigate the clinical efficacy of the combination of enhanced “Shou Tai Wan” soup and progesterone in the treatment of early pre-eclampsia miscarriage. Methods: 86 patients with early pre-eclampsia miscarriage in our hospital from July 2021 to July 2022 were selected and randomly divided into two groups of 43 cases each. The control group was treated with progesterone, while the study group was treated with an addition of enhanced “Shou Tai Wan” soup. The treatment effects of the two groups and the changes in the inflammatory factor levels and sex hormone levels before and after the treatment were observed. Results: INF-? and Il-2 were lower and IL-4 was higher in the study group than in the control group after treatment (p-value < 0.05); the total effective rate of treatment was higher in the study group (95.35%) than in the control group (74.42%), (p-value < 0.05); the levels of P, E2 and ?-hCG were higher in the study group than in the control group after treatment (p-value < 0.05). Conclusion: The combined application of enhanced “Shou Tai Wan” soup and progesterone in patients with early preterm abortion is more effective by improving the patients’ sex hormone levels and reducing the level of inflammatory factors, which is conducive to the improvement of the treatment effect and worthy of promotion.